Towards Healthcare
Marine Biotechnology Market to Drive USD 13.25 Bn by 2034

Marine Biotechnology Market Future Shaped by AI Trends

According to market projections, the marine biotechnology sector is expected to grow from USD 6.72 billion in 2024 to USD 13.25 billion by 2034, reflecting a CAGR of 7.24%. A surge in technological advances and pharmaceutical applications is fueling the global market growth. North America’s ongoing wider demand for nutraceuticals and R&D activities is resulting in its dominance.

  • Insight Code: 6229
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The marine biotechnology market is valued at USD 7.21 billion in 2025 and is on track to reach USD 13.25 billion by 2034, witnessing a steady CAGR of 7.24% during the forecast span.

North America is currently leading the marine biotechnology market share by 40% due to its leading clinical pipelines and nutraceutical demand.

The marine biotechnology market includes 6 segments such as by source/biomass, by application/end-use, by technology/platform, by end user/buyer, by product type, and by region.

Key trends include the escalating demand for nutraceuticals & pharmaceuticals, growth in nanotechnology, and innovations in advanced technologies.

The health benefits of microalgae are rich in nutrients, antioxidant in nature, and its greater sustainability.

NIH, DBT, NIOT, NCSCM, MOES, US FDA, CDSCO, CMFRI, MoFPI.